Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec 28;6(1):dlad145.
doi: 10.1093/jacamr/dlad145. eCollection 2024 Feb.

Resistance to first-line antibiotic therapy among patients with uncomplicated acute cystitis in Melbourne, Australia: prevalence, predictors and clinical impact

Affiliations

Resistance to first-line antibiotic therapy among patients with uncomplicated acute cystitis in Melbourne, Australia: prevalence, predictors and clinical impact

Stephanie J Curtis et al. JAC Antimicrob Resist. .

Abstract

Background: Australian guidelines recommend trimethoprim or nitrofurantoin as first-line agents for uncomplicated urinary tract infections (UTIs). Laboratory surveillance indicates high rates of trimethoprim resistance among urinary bacterial isolates, but there are scant local clinical data about risk factors and impact of trimethoprim resistance.

Objectives: To determine the prevalence, risk factors, mechanism and impact of resistance to first-line antibiotic therapy for uncomplicated UTIs in the community setting.

Methods: A prospective observational study from October 2019 to November 2021 in four general practices in Melbourne, Australia. Female adult patients prescribed an antibiotic for suspected or confirmed uncomplicated acute cystitis were eligible. Primary outcome was urine isolates with resistance to trimethoprim and/or nitrofurantoin.

Results: We recruited 87 participants across 102 UTI episodes with median (IQR) age of 63 (47-76) years. Escherichia coli was the most common uropathogen cultured (48/62; 77%); 27% (13/48) were resistant to trimethoprim (mediated by a dfrA gene) and none were resistant to nitrofurantoin. Isolates with resistance to a first-line therapy were more common among patients reporting a history of recurrent UTIs [risk ratio (RR): 2.08 (95% CI: 1.24-3.51)] and antibiotic use in the previous 6 months [RR: 1.89 (95% CI: 1.36-2.62)]. Uropathogen resistance to empirical therapy was not associated with worse clinical outcomes.

Conclusions: Resistance to trimethoprim is common in uncomplicated UTIs in Australia but may not impact clinical outcomes. Further research is warranted on the appropriateness of trimethoprim as empirical therapy, particularly for patients with antimicrobial resistance risk factors.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Flowchart of study participants, by UTI episode.

Similar articles

Cited by

References

    1. Britt H, Miller GC, Henderson J et al. General Practice Activity in Australia 2015–16. Sydney University Press, 2016.
    1. Jarvis TR, Chan L, Gottlieb T. Assessment and management of lower urinary tract infection in adults. Aust Prescr 2014; 37: 7–9. 10.18773/austprescr.2014.002 - DOI
    1. Wozniak TM, Barnsbee L, Lee XJ et al. Using the best available data to estimate the cost of antimicrobial resistance: a systematic review. Antimicrob Resist Infect Control 2019; 8: 26. 10.1186/s13756-019-0472-z - DOI - PMC - PubMed
    1. Abbott IJ, Peel TN, Cairns KA et al. Antibiotic management of UTI in the post-antibiotic era: a narrative review highlighting diagnostic and antimicrobial stewardship. Clin Microbiol Infec 2022; 29: 1254–66. 10.1016/j.cmi.2022.05.016 - DOI - PubMed
    1. OUTBREAK consortium . A One Health antimicrobial resistance economic perspective. 2020. https://outbreakproject.com.au/wp-content/uploads/2020/12/OUTBREAK_REPOR....

LinkOut - more resources